Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Racadot

Showing results (341-350 of 381) with videos related to

Pageof 39
Sort By:
Hematology and Cell Therapy|May 27, 1999
Low dose T-cell lymphocyte infusion combined with marrow T-cell depletion as prophylaxis of acute graft vs host disease for HLA identical sibling bone marrow transplantationJ Y Cahn, E Deconinck, P Tiberghien, et al.
International Journal of Cancer|August 12, 2023
CANTO skin: Evaluation of skin toxicity risk factors in patients treated for breast cancerSofiane Allali, Matthieu Carton, Sibille Everhard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 6, 2021
[Proposal for the delineation of postoperative primary clinical target volumes in ethmoid cancers]F Guillemin, J Miroir, L Piram, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2023
Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized trialAlicia Le Bras, Yazid Belkacemi, Celine Bourgier, et al.
Head & Neck|October 13, 2021
Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocolElise Rowinski, Nicolas Magné, Jérôme Fayette, et al.
International Journal of Radiation Oncology, Biology, Physics|November 29, 2024
Survival Without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABRJuliette Thariat, Mathieu Bosset, Antoine Falcoz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2012
Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02)Juliette Thariat, René-Jean Bensadoun, Marie-Christine Etienne-Grimaldi, et al.
Bulletin Du Cancer|March 3, 2020
Detailed overview on rare malignant ovarian tumorsStefanie Aust, Lauriane Eberst, Olivier Tredan, et al.
International Journal of Cancer|April 30, 2022
CANTO-RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancerSofiane Allali, Matthieu Carton, Thomas Sarrade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted pictureJuliette Thariat, Marie-Christine Etienne-Grimaldi, Dominique Grall, et al.
Pageof 39

Showing results (341-350 of 381) with videos related to

Sort By:
Pageof 39
Hematology and Cell Therapy|May 27, 1999
Low dose T-cell lymphocyte infusion combined with marrow T-cell depletion as prophylaxis of acute graft vs host disease for HLA identical sibling bone marrow transplantationJ Y Cahn, E Deconinck, P Tiberghien, et al.
International Journal of Cancer|August 12, 2023
CANTO skin: Evaluation of skin toxicity risk factors in patients treated for breast cancerSofiane Allali, Matthieu Carton, Sibille Everhard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 6, 2021
[Proposal for the delineation of postoperative primary clinical target volumes in ethmoid cancers]F Guillemin, J Miroir, L Piram, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2023
Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized trialAlicia Le Bras, Yazid Belkacemi, Celine Bourgier, et al.
Head & Neck|October 13, 2021
Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocolElise Rowinski, Nicolas Magné, Jérôme Fayette, et al.
International Journal of Radiation Oncology, Biology, Physics|November 29, 2024
Survival Without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABRJuliette Thariat, Mathieu Bosset, Antoine Falcoz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2012
Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02)Juliette Thariat, René-Jean Bensadoun, Marie-Christine Etienne-Grimaldi, et al.
Bulletin Du Cancer|March 3, 2020
Detailed overview on rare malignant ovarian tumorsStefanie Aust, Lauriane Eberst, Olivier Tredan, et al.
International Journal of Cancer|April 30, 2022
CANTO-RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancerSofiane Allali, Matthieu Carton, Thomas Sarrade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted pictureJuliette Thariat, Marie-Christine Etienne-Grimaldi, Dominique Grall, et al.
Pageof 39